Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$29,159,057
+$710,886 QoQ
Shares Held
114,813
-1.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
3.56%
of 13F equity value
Holder Rank
#598
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cardinal Capital Management holds $99,250,544 across 9 Drug Manufacturers - General names. JNJ ranks #2 (29.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,505 | $31,790,894 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
114,813 | $29,159,057 | |
| 3 | MRK |
Merck & Co., Inc.
|
96,235 | $12,366,197 | |
| 4 | NVS |
Novartis AG
|
49,670 | $7,784,282 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
105,075 | $6,054,421 | |
| 6 | SNY |
Sanofi
|
80,450 | $3,431,997 | |
| 7 | GSK |
GSK plc
|
62,101 | $3,255,334 | |
| 8 | PFE |
Pfizer Inc
|
124,537 | $2,998,850 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,159,057 | 114,813 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $28,448,171 | 116,381 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $24,235,914 | 117,110 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $21,742,720 | 117,262 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $17,862,890 | 116,942 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $18,763,800 | 113,144 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $14,977,859 | 103,567 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $18,044,570 | 111,345 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $15,705,330 | 107,453 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $16,805,947 | 106,239 | Shares | Sole | 2024-07-12 | |
| 2023-12-31 | $15,771,649 | 100,623 | Shares | Sole | 2024-07-12 | |
| 2023-09-30 | $15,720,782 | 100,936 | Shares | Sole | 2024-07-12 | |
| 2023-06-30 | $16,553,820 | 100,011 | Shares | Sole | 2024-07-12 | |
| 2023-03-31 | $15,379,410 | 99,222 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $17,411,153 | 98,563 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $16,250,562 | 99,477 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $17,682,303 | 99,613 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $17,539,389 | 98,964 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $16,717,302 | 97,722 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $15,787,594 | 97,756 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $16,317,661 | 99,051 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $16,208,197 | 98,620 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $15,502,402 | 98,503 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $14,544,980 | 97,696 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $13,721,972 | 97,575 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $12,825,300 | 97,806 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||